The Manufacturers Life Insurance Company Sells 74,863 Shares of LivaNova PLC $LIVN

Key Points

• The Manufacturers Life Insurance Company reduced its stake in LivaNova PLC by 13.7%, selling 74,863 shares during the first quarter, bringing its total shares down to 471,524.
• Several hedge funds increased their stakes in LivaNova in the fourth quarter, with Jane Street Group LLC leading with a 45.5% increase in ownership.
• LivaNova reported a 10.6% increase in revenue year-over-year, with earnings per share of $1.05 for the last quarter, exceeding the consensus estimate.

The Manufacturers Life Insurance Company lessened its position in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 13.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 471,524 shares of the company's stock after selling 74,863 shares during the period. The Manufacturers Life Insurance Company owned 0.86% of LivaNova worth $18,521,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of LIVN. Mariner LLC increased its stake in LivaNova by 8.4% in the fourth quarter. Mariner LLC now owns 5,741 shares of the company's stock valued at $266,000 after purchasing an additional 446 shares in the last quarter. Hsbc Holdings PLC increased its stake in LivaNova by 25.5% in the fourth quarter. Hsbc Holdings PLC now owns 5,876 shares of the company's stock valued at $272,000 after purchasing an additional 1,193 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in LivaNova by 11.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 37,180 shares of the company's stock valued at $1,722,000 after purchasing an additional 3,839 shares in the last quarter. Northern Trust Corp increased its stake in LivaNova by 11.2% in the fourth quarter. Northern Trust Corp now owns 703,019 shares of the company's stock valued at $32,557,000 after purchasing an additional 70,630 shares in the last quarter. Finally, Jane Street Group LLC increased its stake in LivaNova by 45.5% in the fourth quarter. Jane Street Group LLC now owns 193,826 shares of the company's stock valued at $8,976,000 after purchasing an additional 60,613 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

LIVN has been the subject of several research analyst reports. Wolfe Research raised shares of LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 price target for the company in a research note on Tuesday, May 20th. Needham & Company LLC reaffirmed a "buy" rating and issued a $64.00 price target on shares of LivaNova in a research note on Tuesday, May 13th. Wall Street Zen raised shares of LivaNova from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Barclays lifted their price target on shares of LivaNova from $55.00 to $58.00 and gave the company an "equal weight" rating in a research note on Thursday, August 21st. Finally, Robert W. Baird boosted their target price on shares of LivaNova from $55.00 to $61.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $59.71.

LivaNova Trading Up 1.0%

NASDAQ:LIVN opened at $56.92 on Wednesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.29 and a quick ratio of 1.09. The firm has a 50-day moving average of $47.97 and a 200-day moving average of $43.44. The company has a market cap of $3.11 billion, a PE ratio of -14.63 and a beta of 0.97. LivaNova PLC has a one year low of $32.48 and a one year high of $57.35.

LivaNova (NASDAQ:LIVN - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $1.05 EPS for the quarter, topping the consensus estimate of $0.84 by $0.21. The company had revenue of $352.50 million during the quarter, compared to the consensus estimate of $332.20 million. LivaNova had a negative net margin of 16.13% and a positive return on equity of 14.57%. The firm's revenue for the quarter was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.93 earnings per share. As a group, equities research analysts expect that LivaNova PLC will post 2.85 EPS for the current fiscal year.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.